173 related articles for article (PubMed ID: 22483860)
1. Tooth extraction in patients on zoledronic acid therapy.
Mozzati M; Arata V; Gallesio G
Oral Oncol; 2012 Sep; 48(9):817-21. PubMed ID: 22483860
[TBL] [Abstract][Full Text] [Related]
2. Preventive protocol for tooth extractions in patients treated with zoledronate: a case series.
Ferlito S; Puzzo S; Liardo C
J Oral Maxillofac Surg; 2011 Jun; 69(6):e1-4. PubMed ID: 21316136
[TBL] [Abstract][Full Text] [Related]
3. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
Ferlito S; Liardo C; Puzzo S
Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
[TBL] [Abstract][Full Text] [Related]
4. Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers.
Fleisher KE; Welch G; Kottal S; Craig RG; Saxena D; Glickman RS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):509-16. PubMed ID: 20674404
[TBL] [Abstract][Full Text] [Related]
5. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series.
Lodi G; Sardella A; Salis A; Demarosi F; Tarozzi M; Carrassi A
J Oral Maxillofac Surg; 2010 Jan; 68(1):107-10. PubMed ID: 20006163
[TBL] [Abstract][Full Text] [Related]
6. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
[TBL] [Abstract][Full Text] [Related]
7. Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.
Allen MR; Kubek DJ; Burr DB; Ruggiero SL; Chu TM
Osteoporos Int; 2011 Feb; 22(2):693-702. PubMed ID: 20458574
[TBL] [Abstract][Full Text] [Related]
8. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
[TBL] [Abstract][Full Text] [Related]
10. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
11. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.
Hutchinson M; O'Ryan F; Chavez V; Lathon PV; Sanchez G; Hatcher DC; Indresano AT; Lo JC
J Oral Maxillofac Surg; 2010 Sep; 68(9):2232-40. PubMed ID: 20728032
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
[TBL] [Abstract][Full Text] [Related]
13. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.
Olson KB; Hellie CM; Pienta KJ
Urology; 2005 Sep; 66(3):658. PubMed ID: 16140106
[TBL] [Abstract][Full Text] [Related]
14. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
[No Abstract] [Full Text] [Related]
15. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw.
Biasotto M; Chiandussi S; Zacchigna S; Moimas S; Dore F; Pozzato G; Cavalli F; Zanconati F; Contardo L; Giacca M; Di Lenarda R
J Oral Pathol Med; 2010 May; 39(5):390-6. PubMed ID: 20202091
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
Thumbigere-Math V; Tu L; Huckabay S; Dudek AZ; Lunos S; Basi DL; Hughes PJ; Leach JW; Swenson KK; Gopalakrishnan R
Am J Clin Oncol; 2012 Aug; 35(4):386-92. PubMed ID: 22561331
[TBL] [Abstract][Full Text] [Related]
17. Intravenous bisphosphonate-associated osteonecrosis of the jaw.
Statz TA; Guthmiller JM; Humbert LA; Johnson GK
J Periodontol; 2007 Nov; 78(11):2203-8. PubMed ID: 17970689
[TBL] [Abstract][Full Text] [Related]
18. Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases.
Junquera L; Gallego L; Cuesta P; Pelaz A; de Vicente JC
Am J Otolaryngol; 2009; 30(6):390-5. PubMed ID: 19880027
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.
Nicolatou-Galitis O; Papadopoulou E; Sarri T; Boziari P; Karayianni A; Kyrtsonis MC; Repousis P; Barbounis V; Migliorati CA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):195-202. PubMed ID: 21622014
[TBL] [Abstract][Full Text] [Related]
20. Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis.
Agaçayak KS; Yuksel H; Atilgan S; Koparal M; Uçan MC; Ozgöz M; Yaman F; Atalay Y; Acikan I
Niger J Clin Pract; 2014; 17(5):559-64. PubMed ID: 25244263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
